Suramin potently inhibits binding of the mammalian high mobility group protein AT-hook 2 to DNA
Su, L.; Bryan, N.; Battista, S.; Freitas, J.; Garabedian, A.; DAlessio, F.; Romano, M.; Falanga, F.; Fusco, A.; Kos, L.; Chambers, J.; Fernandez-Lima, F.; Chapagain, P. P.; Vasile, S.; Smith, L.; Leng, F.
Show abstract
The mammalian high mobility group protein AT-hook 2 (HMGA2) is a multi-functional DNA-binding protein which plays important roles in tumorigenesis and adipogenesis. Previous results showed that HMGA2 is a potential therapeutic target of anticancer and anti-obesity drugs by inhibiting its DNA-binding activities. Here we report the development of a miniaturized, automated AlphaScreen high throughput screening (HTS) assay to identify inhibitors targeting HMGA2-DNA interactions. After screening the LOPAC1280 compound library, we discovered that suramin, a negatively charged antiparasitic drug potently inhibits the HMGA2-DNA interaction. Our results also show that the inhibition is through suramin binding to the AT-hooks of HMGA2, therefore blocking its DNA binding capacity. Furthermore, we demonstrate that suramin can induce brain tumor stem cells differentiation into cells with neurite-like structures, a process triggered by disrupting HMGA2-DNA interactions. Since suramin has strong antitumor and anti-metastasis activities, our discovery suggests that HMGA2 and HMGA2-like proteins may be the cellular target of this century-old drug.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Targeting the Protein-Protein Interaction Between the CDC37 Co-Chaperone and Client Kinases by an Allosteric RAF Dimer Breaker 96%
- Binding of single-mutant epidermal growth factor (EGF) ligands alter the stability of the EGF receptor dimer and promote growth signaling 94%
- Methyl-CpG Binding Protein 2 Reads Histone Methylation via an Aromatic Cage to Regulate Gene Expression and Chromatin Association 94%
Similar papers in this journal
Similar papers in this journal
- Cannabinoid Combination Targets NOTCH1-Mutated T-ALL Through the Integrated Stress Response Pathway 94%
- Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer 94%
- A Back-Door Insights into the modulation of Src kinase activity by the polyamine spermidine 94%
Similar papers in this journal
- Computational design of BclxL inhibitors that target transmembrane domain interactions 95%
- An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen. 94%
- More than just an Eagle Killer: The freshwater cyanobacterium Aetokthonos hydrillicola produces highly toxic dolastatin derivatives 94%
Similar papers in this journal
- FDA drug repurposing uncovers modulators of dopamine D2 receptor localization via disruption of the NCS-1 interaction 95%
- Assessment of NR4A Ligands that Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1 94%
- Impact of combinatorial histone modifications on acetyllysine recognition by the ATAD2 and ATAD2B bromodomains 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.